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Aim. Postoperative ileus (POI) is common after surgery. Animal studies indicate that the POImechanism involves an inﬂammatory
response, which is also activated during postoperative complications. This study aimed to determine whether inﬂammatory
biomarkers might facilitate an early detection of prolonged POI (PPOI) or infectious complications. Methods. Forty-seven adult
patients who underwent oncological colorectal surgery were included. They ﬁlled out a perioperative diary to report their
gastrointestinal symptoms. Blood samples were collected preoperatively, and on postoperative day (POD) 1 and 3. Levels of
leucocytes, C-reactive protein (CRP), interleukin (IL)-6, TNF-α, and IL-1β were analyzed. Results. Patients with PPOI had
signiﬁcantly longer stay in hospital than patients without (13.6± 10.5 versus 7.4± 3.2 days, p < 0 001); they also had higher levels
of IL-6 ratios, leucocytes, and CRP levels, but did not reach signiﬁcance. Higher levels of postoperative IL-6 and CRP levels
(p < 0 05, resp.) were found in patients with infectious complications. The receiver operating characteristic (ROC) analysis
found better diagnostic values of IL-6 ratio on both POD 1 and 3 than that of CRP (POD 1: ROC 0.825, p < 0 001).
Conclusion. Blood levels of inﬂammatory cytokines cannot predict PPOI after colorectal surgery. Instead, postoperative IL-6
changes may predict the infectious complications with a better diagnostic value than the current leukocytes or CRP tests.
1. Introduction
Surgical resection is still the cornerstone of colorectal cancer
treatment. Nevertheless, colorectal surgery is associated with
a high morbidity rate of 24–43% [1–3], which signiﬁcantly
compromises a fast recovery after surgery and quality of life
after discharge. Infectious complications including surgical
site infection and anastomotic leakage are the major causes
of postoperative morbidity and mortality [4]. Moreover,
many patients also develop postoperative ileus (POI) charac-
terized by a transient impairment of bowel function and
reduced motility. In some of them, prolonged POI (PPOI)
is diagnosed when POI does not resolve after 5 postoperative
days or recurs after an apparent resolution. Such delayed
recovery of bowel function leads to other serious outcomes
such as longer hospitalization, hospital-acquired infections,
pulmonary compromise, and a large increase of medical cost
as well [5].
Many studies on animal models have revealed that the
mechanism of POI includes an inﬂammatory response
caused by the intestinal manipulation and surgical trauma
[6–8]. Therefore, inﬂammatory markers such as interleukin
(IL)-1β, IL-6, TNF-α, and C-reactive protein (CRP) have
been suggested to be valuable for the early detection of
POI. Previous studies reported that the levels of IL-1β,
IL-6, and TNF-α in PPOI patients were signiﬁcantly higher
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at postoperative day 5 in abdominal drain ﬂuid than that
in normal recoveries [9, 10]. However, due to the wide
application of the ERAS (enhanced recovery after surgery)
program, peritoneal drainage is no longer routine practice
in colorectal patients. In such cases, measuring systematic
levels of the inﬂammatory cytokines seems to be a promising
alternative since it can be easily integrated into postoperative
blood tests.
This approach is supported by animal studies, which
have revealed that elevation of the inﬂammatory cytokines
is also detectable in blood samples in addition to a localized
change [6, 7]. Nevertheless, clinical data to support this are
still not yet available. Moreover, it is important to note that
the classic proinﬂammatory response is also activated in
infectious complications, and increasing levels of the inﬂam-
matory cytokines were also reported in these complications
[11–16]. To this end, we conducted a prospective cohort
study in patients underwent colorectal surgery. In this study,
we analyzed the systemic inﬂammatory markers in perioper-
ative blood samples. The primary goal of this study was to
investigate whether the perioperative inﬂammatory cytokine
levels can predict PPOI. Secondarily, we also tried to associ-
ate the cytokine levels with the infectious complications.
2. Method
2.1. Study Population and Design. Adult patients admitted to
the Academic Colorectal Cancer Center, Havenziekenhuis,
Rotterdam, who underwent oncological colorectal surgery,
were included after informed consent. In total, 50 patients
were planned to be included in this prospective cohort during
the period of November 2013 and November 2014. In
accordance with the Dutch law on medical research in
humans, this study was approved by the Medical Ethical
Committee of the Erasmus University Medical Center,
Rotterdam, Netherlands (permit number: MEC-2013-246,
NL43053.078.13) and patients gave their written consent
after receiving oral and written information.
All patients were asked to ﬁll out a questionnaire before
surgery and every day after surgery until postoperative day
(POD) 7. The questions refer to their food and ﬂuid intake,
bowel movements and defecation, gastrointestinal symp-
toms, and visual analogue scale (VAS) pain score. Data
collection included age, gender, body mass index (BMI),
American Society of Anesthesiologists (ASA) score, medica-
tion use, smoking, operative procedure, and postoperative
complications including anastomotic leakage, fascia dehis-
cence, surgical site infection (SSI), urinary tract infection,
pneumonia, and postoperative course.
2.2. Selection of Variables and Deﬁnitions. To ensure the
objectivity of the primary endpoint, PPOI was not diagnosed
by the participating surgeons but via the retrospective review
of the patient diary and medical record. The participating
doctors diagnosed the other complications based on the
criteria referred from the literature [17–19] (see Table 1).
2.3. Blood Sample Analysis. Peripheral blood was drawn
from each patient before surgery (baseline) and on the
ﬁrst and third postoperative days in the morning, together
with the routine blood tests. Leucocytes and CRP measure-
ments were part of the standardized care and the outcomes
were retrieved from the medical chart. Blood samples were
centrifuged and plasma was stored at −80°C into two ali-
quots for each sample. Enzyme-linked immunosorbent
assays (ELISAs) were performed according to manufacturer’s
instructions to quantify the concentrations of systematic
inﬂammatory markers IL-6 and TNF-α (PeproTech Inc.,
Rocky Hill, USA) and IL-1β (R&D Systems, Minneapolis,
MN, USA) in blood plasma.
Table 1: The variables and deﬁnitions of complication and outcome.
Complications/outcome Deﬁnition
PPOI∗
Resolution of POI is deﬁned as passage of feces with good toleration of solid food for at least 24 hours. PPOI is
diagnosed if POI is not resolved after postoperative day 5; recurrent POI occurring after an apparent resolution
of POI was also deﬁned as PPOI [17, 19].
Anastomotic leakage
Defect of the bowel wall integrity at the anastomotic site. A pelvic abscess close to the anastomosis is also
considered as anastomotic leakage. The diagnosed leakage were Grade B or C according to classiﬁcation of
Rahbari et al. [18].
Surgical site infection (SSI)
Erythema requiring initiation of antibiotic treatment or a wound requiring partial or complete opening for
drainage of a purulent collection.
Pneumonia
Presentation of clinical symptoms including cough, fever, and dyspnoea or consolidation on chest radiography
requiring antibiotic treatment with or without a positive sputum culture.
Urinary tract infection Presents of clinical symptoms, for example, fever, polyuria, and stranguria requiring antibiotic treatment.
Fascia defect Dehiscence of the abdominal wall with or without the need for reoperation.
Reoperation During hospital stay, within 30 days postoperative, or during readmission within 30 days after initial discharge.
Length of hospital stay
Day of admission till the day a patient is ready for discharge; this means patient tolerate solid food and had
passage of feces, and pain is adequately in control with oral analgesics.
Readmission Admission within 30 days after discharge for more than 24 hours.
Mortality Death occurring during hospital stay or within 30 days postoperative.
∗Prolonged postoperative ileus.
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2.4. ERAS Protocol. All patients were treated according to the
ERAS protocol. Two hours before surgery patients preopera-
tively received a carbohydrate-loaded drink. In some cases of
low anterior resection, an enema was given under prescrip-
tion of the surgeon. In general, left-sided colectomy and
(low) anterior resections received bowel preparation with
2 liters of Macrogol 3350 (Klean-Prep 69 gr, Norgine Ltd.,
Hareﬁeld, United Kingdom). Immediately after surgery,
nasogastric tubes were removed and patients are allowed to
move or drink ﬂuid food. Normal diet was oﬀered from the
ﬁrst postoperative day and so on.
2.5. Statistical Analysis. The statistical analysis was carried
out using the Statistical Package for the Social Sciences
(SPSS Inc., Chicago, USA, version 21.0 forWindows). Demo-
graphic data were presented in n (%), mean (SD), or median
(95% conﬁdence interval). Mann–Whitney U test, chi-square
test, Pearson correlation test, and receiver operating charac-
teristic (ROC) analysis were employed according to a proper
indication. A 2-tailed p value< 0.05 was considered to
indicate statistical signiﬁcance.
3. Results
Between October 2013 and November 2014, 54 patients were
included. Among them, three patients were excluded because
of protocol violations of the inclusion criteria, and four
patients retracted the informed consent. In total, 47 patients
were included for analysis.
3.1. PPOI versus Non-PPOI. In total, 72% (34/47) of the
patients recovered from POI within ﬁve postoperative days
(POD 5) and were assigned to the non-PPOI group; 28%
(13/47) patients recovered on or after 6 days postoperatively
(8/13) or had recurrence of POI (5/13) and were therefore
deﬁned as PPOI. Univariate analysis showed a similar base-
line and operative characteristics in the patients with or
without PPOI (Table 2).
IL-6 levels were detectable and measurable in all the
samples. However, TNF-α and IL-1β were not detectable
in the majority of samples. The detailed proportions of
detectable samples are listed in Supplementary Table S1.
The absolute median values of cytokines of positive
samples are presented in Supplementary Table S2. In the
detected samples, we found several samples with substan-
tially higher levels of cytokines compared with other samples,
resulting in a large variation in results. We also found that
cytokine levels of these patients remained high after surgery.
Therefore, a cytokine ratio was calculated with the following
equation: ratio POD1 or 3 = cytokine level on POD1 or 3 /
cytokine level before surgery for further analysis. Cytokine
levels and ratios describe the ratio of cytokine levels at
postoperative days 1 and 3 divided by the preoperative
cytokine level.
The PPOI group showed higher IL-6 ratios on POD
3: 5.90± 9.11 than in the non-PPOI group: 2.44± 3.84
(Figure 1). Due to a low number of valid values, we found
no diﬀerences in IL-1β ratio and TNF-α ratio between the
two groups.
Table 2: Baseline and surgical characteristic comparison between
the PPOI and non-PPOI patients.
Non-PPOI (%) PPOI (%)
n = 34 n = 13
Patient characteristics
Age (yrs.) 67.6± 10.4 71.2± 11.2
Gender
Male 21 (62) 6 (46)
Female 13 (39) 7 (54)
BMI (kg/m2) 27.2± 4.7 24.7± 4.2
ASA score
I 6 (18) 4 (31)
II 14 (41) 4 (31)
III 9 (26) 1 (8)
IV 0 0
Missing 5 (15) 4 (31)
Cardiac comorbidity 11 (32) 3 (23)
Diabetes mellitus 6 (18) 1 (8)
Smoker 6 (18) 1 (8)
COPD 7 (21) 1 (8)
Use of statins 12 (36) 3 (23)
Use of antihypertensive 12 (36) 7 (54)
Neoadjuvant radiotherapy 2 (6) 0
Chemoradiation 4 (12) 1 (8)
Abdominal surgery in history 12 (35) 3 (23)
Operation characteristics
Type of operation
Low anterior resection 10 (29) 2 (15)
Sigmoid resection 6 (18) 2 (15)
Right hemicolectomy 9 (26) 8 (62)
Left hemicolectomy 5 (15) 0
Colon transversum resection 1 (3) 1 (8)
Abdominal perineal resection 3 (9) 0
Approach
Laparotomy 13 (38) 5 (38)
Laparoscopy 20 (59) 7 (54)
Conversion 1 (3) 1 (8)
Stapled versus hand sutured#
Sutured 19 (58) 9 (69)
Stapled 14 (42) 4 (31)
Anastomotic conﬁguration∗
Side-end 10 (29) 5 (42)
Side-side 14 (41) 7 (58)
End-end 6 (18) 0
Stoma construction 11 (32) 2 (13)
Prophylactic drainage 4 (12) 1 (8)
Nasogastric tube∗∗ 10 (29) 6 (50)
PPOI = prolonged postoperative ileus; non-PPOI = patients without PPOI.
Data are n (%), mean (SD). BMI = body mass index; ASA =American
Society of Anesthesiologists classiﬁcation; COPD= chronic obstructive
pulmonary disease; #n = 33 in non-PPOI, n = 13 in PPOI group; ∗n = 30 in
non-PPOI group, n = 12 in PPOI group; ∗∗n = 12 in PPOI group.
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Both leucocytes and CRP were higher in the PPOI group,
but there were no signiﬁcantly diﬀerences between non-
PPOI and PPOI groups at any time point (Figure 2). Also, a
higher postoperative VAS score was seen in the PPOI group,
though no statistical diﬀerence was observed.
In total, 13.0% (6/46) were diagnosed with colorectal
anastomotic leakage. In the PPOI group, a signiﬁcantly
higher percentage of anastomotic leakage was seen, 38.5%
(5/13) versus 3.0% (1/33) in the non-PPOI group, p = 0 005.
The hospital stay duration was signiﬁcant longer in PPOI
patients 13.6± 10.5 versus 7.4± 3.2 in the non-PPOI cases,
p < 0 001 (Figure 2(d)).
3.2. Infectious versus Non-Infectious Complication. There
were no signiﬁcant diﬀerences between the baseline and
surgical characteristic comparison of patients with and
without infectious complications (Supplementary Table S3).
Diﬀerent from the PPOI patients, patients with the infec-
tious complications had signiﬁcantly higher IL-6 ratios
and CRP levels on POD 1 and POD 3 (p < 0 05, respectively,
Figure 3(a)), while the leucocyte count, though also higher,
was not signiﬁcantly diﬀerent from patients without infec-
tious complications, Figure 3(c). Further detailed analysis
showed that signiﬁcantly higher levels of IL-6 ratios on
POD 1 and POD 3 were found in SSI and colorectal anas-
tomotic leakage (CAL) patients as illustrated in Figure 3(a),
while the diﬀerences inCRPwere not signiﬁcant (Figure 3(b)).
No diﬀerences were observed in IL-1β and TNF-α ratios
between the groups.
We performed the ROC analysis to determine the diag-
nostic value of CRP and IL-6 ratio in detection of infectious
complications. Both on POD 1 and POD 3, IL-6 ratio had a
larger area under curve (AUC) than that of CRP (Figure 4).
Further analysis showed that the diagnostic value was
achieved on POD 1 with a cutting-oﬀ point of 1.21 of IL-6
ratio, which yielded a sensitivity of 76% and a speciﬁcity of
86%. Although the sensitivity was relatively low (43%), a
cutting-oﬀ point of 1.93 on POD 1 reached a speciﬁcity of
100%, meaning all patients with an IL-6 ratio higher than
1.93 on POD 1 were diagnosed with infectious complications
later on.
4. Discussion
The importance of developing eﬀective strategies to predict
and eventually to treat the postoperative complications can-
not be overemphasized [20]. In this study, we investigated
the association between the inﬂammatory cytokines and
the postoperative complications. We found that systematic
changes of IL-6 predicted the infectious complications but
not prolonged POI after colorectal surgery.
To develop the eﬀective strategies, researchers depend on
the translational knowledge from animal studies, which have
been continuously contributing to the understanding of POI
mechanism. Several experimental studies have reported the
important role of IL-6 in the development of POI. Even little
manipulation of the bowel induces activity of IL-6, which
results in activation of nitric oxide and prostaglandins and
causes migration of leucocytes into the circular muscle of
the bowel and ends up with PPOI eventually [21–24]. How-
ever, with fruitful data obtained from animal studies, clinical
attempts to predict POI by determining inﬂammatory
mediator levels, the important mechanism in PPOI patho-
physiology, remain limited. Zhu et al. found that peritoneal
levels of IL-1, IL-6, and procalcitonin were higher in PPOI
patients [10], indicating localized parameters are sensitive
for PPOI prediction. Clinical data also found that IL-6 levels
are higher in patients undergoing open surgery when com-
pared with patients undergoing laparoscopic surgery [21],
while open procedures had been demonstrated to delay
recovery of POI [8].
In this study, we report a prospective cohort investigating
the association between the inﬂammatory cytokines and
the postoperative complications. We found that systematic
changes of IL-6 predicted infectious complications but did
not predict PPOI after colorectal surgery. In contrast to
many previous animal studies, our results indicate that
systematic cytokine levels yield poor predictive value in
PPOI diagnosis. This can be partly explained by inevitable
confounding factors (e.g., sex, age, type of surgery, and
preoperative risk factors) in patient subjects which dilute
the inﬂuence of POI on systematic inﬂammatory response
[25], while those factors are usually controlled in animal
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Figure 1: (a) and (b). IL-6 ratio in normal recoveries (non-PPOI) versus PPOI patients, every single dot represents a patient, the line indicates
the median, and there are no signiﬁcant diﬀerences.
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studies. Nevertheless, we believe that our included patients
properly represent the common colorectal patient popula-
tion. An ideal parameter should be able to identify the
high-risk patients. In addition, many animal models used
in POI research have very diﬀerent inﬂammatory response
compared with human [26, 27]. For instance, diﬀerent from
the animal data, our study found that systematic TNF-α
and IL-1β levels were extremely low, which was also
reported by Ellebæk et al. [28]. In addition, our previous
meta-analysis also found that in peritoneal samples, IL-6
is already signiﬁcantly higher in CAL patients on POD 1,
while elevation of TNF-α and IL-1β, both at much lower
concentration, was not observed in the ﬁrst 3 postoperative
days [29].
As is shown in our results, cytokine levels are individually
dependent. This has not yet been previously investigated in
surgical patients. Picotte et al. also reported great variation
in systematic IL-6 levels [30]; therefore, we chose ratio
instead of absolute levels of cytokines to rule out the
individual baseline variations, which resulted in a higher
diagnostic value of the infectious complications than CRP
in the ROC analysis.
Based on our results, it seems that only in severe compli-
cations but not PPOI can the overwhelming inﬂammatory
response be detected in serum in clinical settings. For those
complications, leukocyte count and CRP are commonly used
to assist an early diagnosis [31, 32]; thus, we also included
them into our analysis. In accordance to the previous studies,
our data also support the value of CRP in the diagnosis of
infectious complications. Nevertheless, the ROC analysis
further demonstrates that IL-6 yielded better diagnostic value
than CRP in predicting the infectious complications. It is
important to note that the diagnostic value of IL-6 became
evident very early on POD 1. All patients had a ratio higher
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Figure 2: The leucocyte count and CRP and VAS scores in non-PPOI patients versus PPOI. In panels (a) and (b), bars represent the mean and
error bars the SD. There are no signiﬁcant diﬀerences. Panel (c) presents the VAS (visual analogue scale for pain) score, from postoperative
day 1 up to postoperative day 6. Panel (d) presents patients with or without PPOI and the time in days of being ready for discharge. Patients
with PPOI had a signiﬁcantly longer hospital stay p < 0 001.
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than 1.93 developed infectious complications, indicating the
importance of IL-6 evaluation as a promising innovative
biomarker for clinical practice.
Although many previous studies exclude patients with
other complications from the PPOI group, we still included
them to represent a common patient population. This is
because it is possible to exclude those patients with complica-
tions (e.g., anastomotic leakage) from the POI or PPOI group
in a retrospective database. But in a prospective cohort or
clinical practice, a surgeon has to diﬀerentiate POI or PPOI
from other severe complications that require more invasive
interventions because many infectious complications ﬁrst
manifest abdominal symptoms before systematic manifesta-
tions. This may explain the signiﬁcantly higher rate of the
complications in the PPOI patients in our data.
5. Conclusion
POI remains the most common complication after gastro-
intestinal surgery, without a satisfactory parameter for its
early detection or prediction. In this study, we report a pro-
spective cohort study investigating the association between
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inﬂammatory cytokines and postoperative complications.
We found that serum IL-6 changes predict the infectious
complications but not PPOI after colorectal surgery. How
to translate knowledge from rodent POI studies to clini-
cal practice is evidently an urgent issue to be addressed.
Further exploration of IL-6 seems promising and may
assist an early detection of the infectious complications
after surgery.
Disclosure
G. S. A. Boersema and Z. Wu should both be considered the
ﬁrst authors. This study was presented to the European Colo-
rectal Congress, St. Gallen, Switzerland, December, 2016.
Conflicts of Interest
The authors declare no conﬂict of interest.
Authors’ Contributions
J. F. Lange, J. Jeekel, G. J. Kleinrensink, A. G. Menon, Z.
Wu, and G. S. A. Boersema designed the research; G. S.
A. Boersema and Z. Wu performed the research; G. S.
A. Boersema and Z. Wu analyzed the data; G. S. A. Boersema,
Z. Wu, and J. F. Lange wrote the article, and all authors
drafted the article or revised it critically for important
intellectual content and approved the current version. G. S.
A. Boersema and Z. Wu contributed equally to designing
and performing the trial, data interpretation, and writing of
the manuscript.
Acknowledgments
The authors would like to thank all medical assistance from
the Academic Colorectal Cancer Center, Havenziekenhuis,
Rotterdam, for their help. This studywas funded by “Stichting
Coolsingel”, Rotterdam; BeijingMunicipal Science and Tech-
nology Project, Beijing Municipal Science and Technology
Commission (D141100000414004); and Program for Clinical
Application and Development, Beijing Municipal Science
and Technology Commission (Z151100004015070).
Supplementary Materials
Table S1: percentage of positive samples in the non-PPOI and
PPOI group. Table S2: absolute level of cytokine in plasma of
the positive samples. Table S3: baseline and surgical charac-
teristic comparison between patients with infectious compli-
cations and normal recovery. (Supplementary Materials)
1.00.80.60.4
1 – specificity
(a) (b)
1 – specificity
0.20.0
Se
ns
iti
vi
ty
Se
ns
iti
vi
ty
1.0
IL-6 ratio
CRP
Reference line
0.8
0.6
0.4
0.2
0.0
ROC curve
ROC curve
1.00.80.60.40.20.0
1.0
0.8
0.6
0.4
0.2
0.0
IL-6 ratio
CRP
Reference line
POD Biomarker AUC SE p 95% Cl
0.732
0.825
0.731
0.801
0.078
0.067
0.077
0.068
0.010 0.579
0.693
0.580
0.668
0.884
0.956
0.882
0.934
<0.001
0.008
0.001
CRP
IL‑6
CRP
IL‑6
POD 1
POD 3
Figure 4: ROC analysis showed CRP and IL-6 ratio on POD 1 (a) and POD 3 (b), on both days; the AUC was higher in IL-6 ratio.
7Mediators of Inﬂammation
References
[1] A. Alves, Y. Panis, P. Mathieu et al., “Mortality and morbidity
after surgery of mid and low rectal cancer: results of a French
prospective multicentric study,” Gastroentérologie Clinique et
Biologique, vol. 29, no. 5, pp. 509–514, 2005.
[2] A. Alves, Y. Panis, P. Mathieu et al., “Postoperative mortality
and morbidity in french patients undergoing colorectal sur-
gery: results of a prospective multicenter study,” Archives of
Surgery, vol. 140, no. 3, pp. 278–283, 2005.
[3] A. Alves, Y. Panis, K. Slim et al., “French multicentre prospec-
tive observational study of laparoscopic versus open colectomy
for sigmoid diverticular disease,” The British Journal of
Surgery, vol. 92, no. 12, pp. 1520–1525, 2005.
[4] P. Kirchhoﬀ, P. A. Clavien, and D. Hahnloser, “Complications
in colorectal surgery: risk factors and preventive strategies,”
Patient Safety in Surgery, vol. 4, no. 1, p. 5, 2010.
[5] R. Schuster, N. Grewal, G. C. Greaney, and K. Waxman, “Gum
chewing reduces ileus after elective open sigmoid colectomy,”
Archives of Surgery, vol. 141, no. 2, pp. 174–176, 2006.
[6] J. C. Kalﬀ, W. H. Schraut, R. L. Simmons, and A. J. Bauer,
“Surgical manipulation of the gut elicits an intestinal muscu-
laris inﬂammatory response resulting in postsurgical ileus,”
Annals of Surgery, vol. 228, no. 5, pp. 652–663, 1998.
[7] A. Turler, B. A. Moore, M. A. Pezzone, M. Overhaus,
J. C. Kalﬀ, and A. J. Bauer, “Colonic postoperative inﬂamma-
tory ileus in the rat,” Annals of Surgery, vol. 236, no. 1,
pp. 56–66, 2002.
[8] A. J. Bauer and G. E. Boeckxstaens, “Mechanisms of postoper-
ative ileus,” Neurogastroenterology & Motility, vol. 16, no. S2,
pp. 54–60, 2004.
[9] P. Zhu, Z. Liang, J. Fu et al., “Procalcitonin in abdominal
exudate to predict prolonged postoperative ileus following
colorectal carcinoma surgery,” The International Journal of
Biological Markers, vol. 28, no. 2, pp. 187–191, 2013.
[10] P. Zhu, H. Jiang, J. Fu, W. Chen, Z. Wang, and L. Cui,
“Cytokine levels in abdominal exudate predict prolonged post-
operative ileus following surgery for colorectal carcinoma,”
Oncology Letters, vol. 6, no. 3, pp. 835–839, 2013.
[11] T. C. D. Rettig, L. Verwijmeren, I. M. Dijkstra, D. Boerma,
E. M. W. van de Garde, and P. G. Noordzij, “Postoperative
interleukin-6 level and early detection of complications
after elective major abdominal surgery,” Annals of Surgery,
vol. 263, no. 6, pp. 1207–1212, 2016.
[12] I. Dimopoulou, A. Armaganidis, E. Douka et al., “Tumour
necrosis factor-alpha (TNFα) and interleukin-10 are crucial
mediators in post-operative systemic inﬂammatory response
and determine the occurrence of complications after major
abdominal surgery,” Cytokine, vol. 37, no. 1, pp. 55–61, 2007.
[13] D. Mokart, M. Merlin, A. Sannini et al., “Procalcitonin,
interleukin 6 and systemic inﬂammatory response syndrome
(SIRS): early markers of postoperative sepsis after major
surgery,” British Journal of Anaesthesia, vol. 94, no. 6,
pp. 767–773, 2005.
[14] H. Korner, H. J. Nielsen, J. A. Soreide, B. S. Nedrebo,
K. Soreide, and J. C. Knapp, “Diagnostic accuracy of
C-reactive protein for intraabdominal infections after colo-
rectal resections,” Journal of Gastrointestinal Surgery, vol. 13,
no. 9, pp. 1599–1606, 2009.
[15] P. Matthiessen, M. Henriksson, O. Hallbook, E. Grunditz,
B. Noren, and G. Arbman, “Increase of serum C-reactive
protein is an early indicator of subsequent symptomatic
anastomotic leakage after anterior resection,” Colorectal
Disease, vol. 10, no. 1, pp. 75–80, 2008.
[16] Y. Takakura, T. Hinoi, H. Egi et al., “Procalcitonin as a
predictive marker for surgical site infection in elective colorec-
tal cancer surgery,” Langenbeck's Archives of Surgery, vol. 398,
no. 6, pp. 833–839, 2013.
[17] R. Vather, S. Trivedi, and I. Bissett, “Deﬁning postoperative
ileus: results of a systematic review and global survey,” Journal
of Gastrointestinal Surgery, vol. 17, no. 5, pp. 962–972, 2013.
[18] N. N. Rahbari, J. Weitz, W. Hohenberger et al., “Deﬁnition and
grading of anastomotic leakage following anterior resection of
the rectum: a proposal by the International Study Group of
Rectal Cancer,” Surgery, vol. 147, no. 3, pp. 339–351, 2010.
[19] A. Artinyan, J. W. Nunoo-Mensah, S. Balasubramaniam et al.,
“Prolonged postoperative ileus—deﬁnition, risk factors, and
predictors after surgery,” World Journal of Surgery, vol. 32,
no. 7, pp. 1495–1500, 2008.
[20] S. ter Hoeve-Boersema, Major Abdominal Surgical Compli-
cations: Innovative Approaches, [Ph.d. thesis], Erasmus
University Rotterdam, Rotterdam, Netherlands, 2017.
[21] R. Frasko, P. Maruna, R. Gurlich, and S. Trca, “Transcutane-
ous electrogastrography in patients with ileus. Relations to
interleukin-1β, interleukin-6, procalcitonin and C-reactive
protein,” European Surgical Research, vol. 41, no. 2, pp. 197–
202, 2008.
[22] M. Overhaus, S. Togel, M. A. Pezzone, and A. J. Bauer,
“Mechanisms of polymicrobial sepsis-induced ileus,”American
Journal of Physiology-Gastrointestinal and Liver Physiology,
vol. 287, no. 3, pp. G685–G694, 2004.
[23] H. Törnblom, H. Abrahamsson, G. Barbara et al.,
“Inﬂammation as a cause of functional bowel disorders,”
Scandinavian Journal of Gastroenterology, vol. 40, no. 10,
pp. 1140–1148, 2005.
[24] S. Wehner, N. T. Schwarz, R. Hundsdoerfer et al., “Induction
of IL-6 within the rodent intestinal muscularis after intestinal
surgical stress,” Surgery, vol. 137, no. 4, pp. 436–446, 2005.
[25] Z. Wu, G. S. A. Boersema, A. Dereci, A. G. Menon, J. Jeekel,
and J. F. Lange, “Clinical endpoint, early detection, and diﬀer-
ential diagnosis of postoperative ileus: a systematic review of
the literature,” European Surgical Research, vol. 54, no. 3-4,
pp. 127–138, 2015.
[26] A. C. Drake, “Of mice and men: what rodent models don’t
tell us,” Cellular & Molecular Immunology, vol. 10, no. 4,
pp. 284-285, 2013.
[27] J. Seok, H. S. Warren, A. G. Cuenca et al., “Genomic
responses in mouse models poorly mimic human inﬂamma-
tory diseases,” Proceedings of the National Academy of
Sciences of the United States of America, vol. 110, no. 9,
pp. 3507–3512, 2013.
[28] M. B. Ellebæk, G. Baatrup, J. Gjedsted, C. Fristrup, and
N. Qvist, “Cytokine response in peripheral blood indicates
diﬀerent pathophysiological mechanisms behind anastomotic
leakage after low anterior resection: a pilot study,” Techniques
in Coloproctology, vol. 18, no. 11, pp. 1067–1074, 2014.
[29] C. L. Sparreboom, Z. Wu, A. Dereci et al., “Cytokines as early
markers of colorectal anastomotic leakage: a systematic review
and meta-analysis,” Gastroenterology Research and Practice,
vol. 2016, Article ID 3786418, 11 pages, 2016.
[30] M. Picotte, C. G. Campbell, and W. G. Thorland, “Day-to-day
variation in plasma interleukin-6 concentrations in older
adults,” Cytokine, vol. 47, no. 3, pp. 162–165, 2009.
8 Mediators of Inﬂammation
[31] T. Welsch, S. A. Müller, A. Ulrich et al., “C-reactive protein as
early predictor for infectious postoperative complications in
rectal surgery,” International Journal of Colorectal Disease,
vol. 22, no. 12, pp. 1499–1507, 2007.
[32] P. Ortega-Deballon, F. Radais, O. Facy et al., “C-reactive
protein is an early predictor of septic complications after
elective colorectal surgery,” World Journal of Surgery, vol. 34,
no. 4, pp. 808–814, 2010.
9Mediators of Inﬂammation
Stem Cells 
International
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
MEDIATORS
INFLAMMATION
of
Endocrinology
International Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
Disease Markers
Hindawi
www.hindawi.com Volume 2018
BioMed 
Research International
Oncology
Journal of
Hindawi
www.hindawi.com Volume 2013
Hindawi
www.hindawi.com Volume 2018
Oxidative Medicine and 
Cellular Longevity
Hindawi
www.hindawi.com Volume 2018
PPAR Research
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2013www.hindawi.com
The Scientific 
World Journal
8
Immunology Research
Hindawi
www.hindawi.com Volume 2018
Journal of
Obesity
Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
 Computational and  
Mathematical Methods 
in Medicine
Hindawi
www.hindawi.com Volume 2018
Behavioural 
Neurology
Ophthalmology
Journal of
Hindawi
www.hindawi.com Volume 2018
Diabetes Research
Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
Research and Treatment
AIDS
Hindawi
www.hindawi.com Volume 2018
Gastroenterology 
Research and Practice
Hindawi
www.hindawi.com Volume 2018
Parkinson’s 
Disease
Evidence-Based 
Complementary and
Alternative Medicine
Volume 2018
Hindawi
www.hindawi.com
Submit your manuscripts at
www.hindawi.com
